Open Offer Letter filed for Bliss GVS Pharma at INR 299 per share

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.3%Reaction day

₹467.60

prior close

₹461.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.2%-3.1% vs market

Pharmaceuticals peers, median of 165sector-1.6%-2.7% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.2

10m

-1.4

15m

-1.7

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.3-1.2-3.1-1.6-2.7

Next day

-1.0-1.9+0.8-2.5+1.4

-1.2-1.4+0.2-2.5+1.3

-2.4-0.1-2.2-1.3-1.1

-3.5-1.4-2.1-2.4-1.2

-2.7-1.0-1.7-1.7-1.0

-0.7-0.4-0.3-2.1+1.4

15d

+4.8+3.2+1.6-0.3+5.1

+19.8+4.4+15.4-1.1+20.9

+48.5+4.6+44.0+0.8+47.7

+37.4-3.6+41.0-6.6+44.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SBI Capital Markets submitted the Letter of Offer for an open offer to acquire up to 2,77,26,848 equity shares (26% of expanded voting share capital) of Bliss GVS Pharma at INR 299 per share. Anupam Rasayan India Limited is the acquirer, with Mates Visa Consultancy as PAC. Maximum consideration: INR 829 crore. Tendering period runs July 28 to August 10, 2026.

Likely market impact

Public shareholders can tender shares at INR 299 per share. Stock may see volatility near tendering dates as the acquirer signals strategic interest in the company.